Comparison of Breast Cancer Recurrence and Outcome Patterns
CONSORT diagram. aPatients who had surgery; bPatients with
Safety, activity, and molecular heterogeneity following
Current Oncology, Free Full-Text
Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel
Frontiers Long-Term Cardiac Safety and Survival Outcomes of
Controlling angiogenesis in breast cancer: A systematic review of
Gemcitabine as adjuvant chemotherapy in patients with high-risk
Impact of HER2-low status for patients with early-stage breast
Frontiers Triple-negative and Her2-positive breast cancer in
Final results from the prospective phase III WSG-ARA trial: impact
Alterations in immune cell phenotype and cytotoxic capacity in
PDF) Definitive Results of a Phase III Adjuvant Trial Comparing